首页> 中文期刊> 《中国化学快报:英文版》 >Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors

Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors

         

摘要

Two series of sulfur-containing diarylbenzopyrimidines are designed by the fragment combination of a thioacetamide with our previous disclosed DABP 3 and further oxidation.The best compound 6 e with a sulfonyl scaffold displayed EC(50)values of 0.0356μmol/L against WT and 0.0228μmol/L against HIV K103 N mutant strain.More pronounced,it had a lower cytotoxicity(CC(50)=99.6μmol/L),higher selectivity index(SIWT=2799,SIK103 N=4375)and better calculated logarithm of the octanol-water partition coefficient(cLogP)than the lead compound 3.Molecular docking and dynamics provided the binding modes of these compounds with reve rse transcriptase,explaining their activity.Collectively,the new compounds could be candidates for anti-HIV drug discovery.

著录项

  • 来源
    《中国化学快报:英文版》 |2020年第3期|764-768|共5页
  • 作者单位

    Engineering Center of Catalysis and Synthesis for Chiral Molecules;

    Department of Chemistry;

    Fudan University;

    Shanghai 200433;

    China;

    Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs;

    Shanghai 200433;

    China;

    Sichuan Research Center for Drug Precision Industrial Technology;

    West China School of Pharmacy;

    Sichuan University;

    Chengdu 610041;

    China;

    Institute of Pharmaceutical Science and Technology;

    Zhejiang University of Technology;

    Hangzhou 310014;

    China;

    Rega Institute for Medical Research;

    KU Leuven;

    Herestraat 49;

    B-3000 Leuven;

    Belgium;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 TQ463.5;
  • 关键词

    HIV-1; NNRTIs; DAPY; Sulfur-containing; DABPs; FBDD;

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号